- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03874728
The Effects of Minimal Shoes in Older People at Risk of Falls: The Feetback Shoe Study (FSS)
July 3, 2020 updated by: Tomasz Cudejko, University of Liverpool
Preventing Falls in Older People Using an Innovative Connected Shoe: Development & Biomechanics Study.
A third of people over 65, and half of people over 80, fall at least once a year.
Falls are the most common cause of death from injury in the over 65s and result in a significant financial burden on the whole society.
Shoes directly influence balance, gait, and the subsequent risk of slips, trips and falls by altering somatosensory feedback to the foot and ankle.
Minimal shoes, that is shoes lacking a firm heel cup, a rigid sole or longitudinal arch support, have shown advantages in strengthening muscles and improving balance as compared to conventional shoes.
However, limited research has studied the effect of minimal shoe in older people at risk of falls.
The aim of the project will be to assess the effects of minimal shoes in older people at risk of falls, compared to conventional shoes and barefoot.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Study participants will attend a one-day testing session at the Movement Laboratory, University of Liverpool.
Participants will be subjected to several standing and walking tests while wearing three types of footwear in a randomised order: (i) a minimal shoe, (ii) a conventional shoe, and (iii) barefoot.
Participants' physical function, stability during standing and walking and an activity of lower leg muscles will be assessed in each of those three footwear conditions.
Participants will also be asked about perceptions of footwear, regarding a minimal shoe and a conventional shoe.
At the end of assessments, participants will be asked to complete several walking bouts while wearing a minimal shoe with "smart" shoe insoles, to determine "smart" insoles' validity in obtaining gait characteristics against a gold standard measure.
Finally, those participants who volunteer to take part in a two-week follow-up study, will be asked to wear the minimal shoes with "smart" insoles during daily life for two weeks, After two weeks, they will be asked to fill in an online questionnaire asking them about total time they used the minimal shoes and insoles and about how satisfied they were with them.
Study Type
Observational
Enrollment (Actual)
30
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Merseyside
-
Liverpool, Merseyside, United Kingdom, L8 0TL
- University of Liverpool
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Community-dwelling older adults
Description
Inclusion Criteria:
- Age: ≥ 60 years old
One of the vulnerability criteria for risk falls:
(i) ≥ 1 self-reported falls after the age of 60; (ii) balance impairment as indicated by a score <45 on the Berg Balance Scale, by a score >2 on the simplified Tinetti Gait & Balance test or via any other validated and reliable clinical instrument used at the recruitment site; (iii) one or two criteria for physical frailty
Exclusion Criteria:
- Macro-vascular symptoms (angina, stroke or a peripheral vascular disease)
- Neuromuscular diseases (Multiple Sclerosis, Alzheimer Disease or Parkinson Disease)
- Diabetes
- Use of a walking aid (cane or walker)
- Ankle, knee, hip surgery ≤ 3 months
- Pain in the lower extremities of ≥ 8 on the numeric rating scale
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Older people at risk of falls
|
A minimal shoe (Vivobarefoot Ltd., London, UK) will be used.
The Go Walk 4.0-Pursuit shoe for women (Skechers USA, Inc.) and the Superior 2.0-Jeveno shoe for men (Skechers USA, Inc) will be used.
Participants will conduct the assessments barefoot.
Arion pressure-measuring insoles (Eindhoven, The Netherlands) will be used in the study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Timed Up and Go test
Time Frame: First day of joining the study
|
Time (in seconds) to complete the Timed Up and Go test
|
First day of joining the study
|
Star Excursion Balance Test
Time Frame: First day of joining the study
|
Reach (in centimetres) to achieve during the Star Excursion Balance Test
|
First day of joining the study
|
Postural stability
Time Frame: First day of joining the study
|
Anterior-Posterior and latero-medial movement (in centimetres) of the centre of pressure
|
First day of joining the study
|
Dynamic stability
Time Frame: First day of joining the study
|
Variability (standard deviations) of spatio-temporal gait characteristics
|
First day of joining the study
|
Muscle activity
Time Frame: First day of joining the study
|
Electromyography activity for selected lower leg muscles and expressed in millivolts
|
First day of joining the study
|
Perceived attractiveness
Time Frame: First day of joining the study
|
Scored on a 100-millimetres (mm) visual analogue scale with 0 mm being "extremely unattractive" and 100 mm being "extremely attractive"
|
First day of joining the study
|
Perceived attractiveness for others
Time Frame: First day of joining the study
|
Scored on a 100-millimetres (mm) visual analogue scale with 0 mm being "extremely unattractive for others" and 100 mm being "extremely attractive for others"
|
First day of joining the study
|
Perceived comfort
Time Frame: First day of joining the study
|
Scored on a 100-millimetres (mm) visual analogue scale with 0 mm being "extremely uncomfortable" and 100 mm being "extremely comfortable"
|
First day of joining the study
|
Perceived weight
Time Frame: First day of joining the study
|
Scored on a 100-millimetres (mm) visual analogue scale with 0 mm being "extremely light" and 100 mm being "extremely heavy"
|
First day of joining the study
|
Perceived fit
Time Frame: First day of joining the study
|
Scored on a 100-millimetres (mm) visual analogue scale with 0 mm being "poorest fit possible" and 100 mm being "best fit possible"
|
First day of joining the study
|
Perceived ease of use
Time Frame: First day of joining the study
|
Scored on a 100-millimetres (mm) visual analogue scale with 0 mm being "most difficult as possible" and 100 mm being "as easy as imaginable"
|
First day of joining the study
|
Perceived stability
Time Frame: First day of joining the study
|
Scored on a 100-millimetres (mm) visual analogue scale with 0 mm being "extremely unstable" and 100 mm being "extremely stable"
|
First day of joining the study
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Validity of "smart" shoe insoles
Time Frame: First day of joining the study
|
Validity of Arion insoles against Qualisys Motion Capture System
|
First day of joining the study
|
Adherence to wearing minimal shoes in daily life
Time Frame: The assessment will be performed at 2 weeks
|
Adherence to wearing minimal shoes with "smart" shoe insoles assessed with an online questionnaire and expressed in total time in days and hours
|
The assessment will be performed at 2 weeks
|
Satisfaction of wearing minimal shoes in daily life
Time Frame: The assessment will be performed at 2 weeks
|
Satisfaction of wearing minimal shoes with "smart" shoe insoles assessed with an online questionnaire and expressed on a 5-point Likert scale, with the following levels: 1 - Very dissatisfied, 2 - dissatisfied, 3 - unsure, 4 - satisfied, 5 - Very satisfied.
|
The assessment will be performed at 2 weeks
|
Gait characteristics during daily life
Time Frame: The assessment will be performed at 2 weeks
|
Gait characteristics, assessed with "smart" shoe insoles, during activities of daily life and expressed in spatio-temporal metrics
|
The assessment will be performed at 2 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Kristiaan D'Août, PhD, University of Liverpool
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
November 20, 2019
Primary Completion (ACTUAL)
March 1, 2020
Study Completion (ACTUAL)
March 1, 2020
Study Registration Dates
First Submitted
March 12, 2019
First Submitted That Met QC Criteria
March 12, 2019
First Posted (ACTUAL)
March 14, 2019
Study Record Updates
Last Update Posted (ACTUAL)
July 7, 2020
Last Update Submitted That Met QC Criteria
July 3, 2020
Last Verified
July 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- 4151
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aging
-
Tuba MadenCompletedAging | Aging Problems | Aging Disorder
-
Radboud University Medical CenterNot yet recruitingAging | Aging Well | Immuno Aging
-
University of Santiago de CompostelaEuropean Regional Development Fund; Center for Industrial Technological Development...Completed
-
TruDiagnosticBlushield USANot yet recruitingAging | Aging Well
-
San Diego State UniversityCompleted
-
Lithuanian Sports UniversityCompletedAging | Healthy AgingLithuania
-
University of West AtticaNot yet recruiting
-
University of Santiago de CompostelaAgencia Estatal de Investigación, SpainRecruiting
-
Beijing HospitalBGI-ShenzhenCompletedAging | Healthy Aging
-
Amazentis SAproDERM GmbHCompleted
Clinical Trials on Minimal shoes
-
University of South FloridaNational Institute on Aging (NIA); University of HartfordRecruitingPlantar Fasciitis, ChronicUnited States
-
Eastern Mediterranean UniversityCompleted
-
University Hospital, BrestCompleted
-
University Hospital, Basel, SwitzerlandCompletedCerebral PalsySwitzerland
-
Assaf-Harofeh Medical CenterUnknownCerebral Palsy | Poststroke/CVA ParesisIsrael
-
University Hospital, GenevaCompleted
-
IRCCS National Neurological Institute "C. Mondino...Not yet recruitingParkinson Disease | Gait Disorders
-
Centre Hospitalier Universitaire de Saint EtienneCompleted
-
Centre Hospitalier Universitaire de Saint EtienneCompleted
-
Bijan Najafi, PhDOrthofeet, Inc.CompletedFoot PainUnited States